Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 826 of 3330
Next
>>
>
20626 to 20650 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.4	uM	7873.002	0.2377	-0.0134	2.0331
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	2	uM	7873.002	0.2743	0.0585	2.0331
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	10	uM	7873.002	0.3021	0.1100	2.0331
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.0000256	uM	10061.002	1.0218	1.0232	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.000128	uM	10061.002	1.1411	1.1458	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.00064	uM	10061.002	0.9469	0.9426	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.0032	uM	10061.002	0.8341	0.8156	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.016	uM	10061.002	0.6349	0.5698	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.08	uM	10061.002	0.5656	0.4760	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.4	uM	10061.002	0.4954	0.3753	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	2	uM	10061.002	0.5857	0.5038	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	10	uM	10061.002	0.5588	0.4666	1.8759
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.0000256	uM	12949.002	0.8688	0.8454	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.000128	uM	12949.002	1.0417	1.0473	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.00064	uM	12949.002	0.8451	0.8164	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.0032	uM	12949.002	0.5927	0.4828	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.016	uM	12949.002	0.4092	0.1997	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.08	uM	12949.002	0.3570	0.1096	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	0.4	uM	12949.002	0.3210	0.0441	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	2	uM	12949.002	0.3341	0.0683	1.7484
MCF12A	NM	Basal B	Docetaxel	TUBB	TUBB	10	uM	12949.002	0.3699	0.1324	1.7484
MCF7	HR+	Luminal	Docetaxel	TUBB	TUBB	0.0000256	uM	7875.002	0.9904	0.9895	1.8262
MCF7	HR+	Luminal	Docetaxel	TUBB	TUBB	0.000128	uM	7875.002	0.9508	0.9455	1.8262
MCF7	HR+	Luminal	Docetaxel	TUBB	TUBB	0.00064	uM	7875.002	0.9831	0.9814	1.8262
MCF7	HR+	Luminal	Docetaxel	TUBB	TUBB	0.0032	uM	7875.002	0.7724	0.7363	1.8262

|<
<<
Previous
Page 826 of 3330
Next
>>
>
20626 to 20650 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)